Funded Startups in Stevenage
Seven funded startups in Stevenage are listed here, with biotech dominating the set: 6 of 7 companies are in Biotechnology (Laverock Therapeutics on 2026-0…
Seven funded startups in Stevenage are listed here, with biotech dominating the set: 6 of 7 companies are in Biotechnology (Laverock Therapeutics on 2026-06-01 at $3M; Civo is the only non-biotech entry at $2M on 2021-09-17; the rest are biotech). Disclosed round sizes show a clear outlier: Gyroscope Therapeutics raised $149M on 2021-03-26, which dwarfs the next-largest disclosed amounts ($44M for ReViral on 2020-08-25 and $28M for NeRRe Therapeutics on 2021-07-07).
Timing clusters around 2020–2021: 5 of the 7 rows fall between 2020-08-25 (ReViral) and 2021-09-17 (Civo). The most recent disclosed round is Laverock Therapeutics on 2026-06-01 at $3M, while the smallest disclosed amount in the table is also $2M (Civo on 2021-09-17). No “Series Unknown”/undisclosed amount pattern appears in the amounts shown beyond one missing round-type label for Myricx Pharma (2020-11-16, $5M) and another for ReViral (2020-08-25, $44M).
Most recent rounds
7 shownRelated listings
Frequently asked
What stands out in disclosed round sizes for Stevenage, and how does the largest round compare to the rest?
Gyroscope Therapeutics’ $149M round on 2021-03-26 is the dominant outlier in the table; the next-largest disclosed amounts are $44M (ReViral, 2020-08-25) and $28M (NeRRe Therapeutics, 2021-07-07), with everything else below $26M.
How concentrated are the funding dates in this list?
Five of the seven entries were dated between 2020-08-25 (ReViral) and 2021-09-17 (Civo). The span of rounds shown runs from 2020-08-25 through the most recent 2026-06-01 entry (Laverock Therapeutics at $3M).
Is the sector mix skewed toward one area?
Biotechnology appears in 6 of 7 companies (Laverock Therapeutics, Freeline, NeRRe Therapeutics, Gyroscope Therapeutics, Myricx Pharma, ReViral). The only non-biotech entry is Civo (Hardware) with a disclosed $2M round on 2021-09-17.
Which stage labels dominate among disclosed amounts, and where do the biggest rounds sit?
Stage labels vary across the set, but “Series B” and “Series C” each appear once (NeRRe Therapeutics at $28M on 2021-07-07; Gyroscope Therapeutics at $149M on 2021-03-26). “Post-IPO Equity” appears once for Freeline at $26M on 2022-03-10, while two entries show blank stage labels despite disclosed amounts ($5M for Myricx Pharma on 2020-11-16; $44M for ReViral on 2020-08-25).
Are there any smaller-round clusters near the low end of disclosed amounts?
At the low end, the smallest disclosed amount is $2M for Civo on 2021-09-17, with another low disclosed amount of $3M for Laverock Therapeutics on 2026-06-01. Most other disclosed rounds are materially higher (e.g., $5M on 2020-11-16 for Myricx Pharma and $28M–$44M for NeRRe Therapeutics and ReViral).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.